RESUMO
OBJECTIVE: microRNAs (miRNAs) play critical roles in embryogenesis, cell differentiation and the pathogenesis of several human diseases, including systemic lupus erythematosus (SLE). Toll-like receptors (TLRs) are also known to exert crucial functions in the immune response activation occurring in the pathogenesis of autoimmune diseases like SLE. Herein, the current study aimed to explore the potential role of miR-152-3p in TLR-mediated inflammatory response in SLE. METHODS: We determined the miR-152-3p expression profiles in CD4+ T cells and peripheral blood mononuclear cells (PBMCs) harvested from patients with SLE and healthy controls, and analyzed the correlation between miR-152-3p expression and clinicopathological parameters. CD70 and CD40L expression patterns in CD4+ T cells were assessed by RT-qPCR and flow cytometry. ChIP was adopted to determine the enrichment of DNA methyltransferase 1 (DNMT1) in the promoter region of myeloid differentiation factor 88 (MyD88). RESULTS: The obtained findings revealed that miR-152-3p was highly-expressed in CD4+ T cells and PBMCs of patients with SLE, and this high expression was associated with facial erythema, joint pain, double-stranded DNA, and IgG antibody. DNMT1 could be enriched in the MyD88 promoter, and miR-152-3p inhibited the methylation of MyD88 by targeting DNMT1. We also found that silencing miR-152-3p inhibited MyD88 expression not only to repress the autoreactivity of CD4+ T cells and but also to restrain their cellular inflammation, which were also validated in vivo. CONCLUSION: Our study suggests that miR-152-3p promotes TLR-mediated inflammatory response in CD4+ T cells by regulating the DNMT1/MyD88 signaling pathway, which highlights novel anti-inflammatory target for SLE treatment.
Assuntos
Lúpus Eritematoso Sistêmico/genética , MicroRNAs , Adolescente , Adulto , Idoso , Animais , Anticorpos Anti-Idiotípicos/sangue , Anticorpos Antinucleares/sangue , Artralgia/genética , Artralgia/imunologia , Criança , Citocinas/imunologia , DNA (Citosina-5-)-Metiltransferase 1/genética , DNA (Citosina-5-)-Metiltransferase 1/imunologia , Desmetilação , Eritema/genética , Eritema/imunologia , Face , Feminino , Humanos , Inflamação/genética , Inflamação/imunologia , Leucócitos Mononucleares/imunologia , Lúpus Eritematoso Sistêmico/imunologia , Masculino , Camundongos Endogâmicos MRL lpr , Pessoa de Meia-Idade , Fator 88 de Diferenciação Mieloide/imunologia , Receptores Toll-Like/imunologia , Adulto JovemRESUMO
Epidermolysis bullosa simplex migratory circinate erythema (EBS-Migr) is an uncommon subtype of EBS. We report a case of EBS-MIGR with a novel heterozygous pathogenic mutation in exon 9 (frameshift deletion c.1650delC) and likely benign heterozygous mutation in exon 2 (missense c.591C > A) of keratin 5. This novel pathogenic mutation in KRT5 expands the molecular spectrum of this rare subtype of EBS.
Assuntos
Epidermólise Bolhosa Simples/genética , Epidermólise Bolhosa Simples/patologia , Eritema/genética , Eritema/patologia , Queratina-5/genética , Mutação/genética , Pré-Escolar , Humanos , MasculinoRESUMO
BACKGROUND: Terrestrial ultraviolet (UV) radiation causes erythema, oxidative stress, DNA mutations and skin cancer. Skin can adapt to these adverse effects by DNA repair, apoptosis, keratinization and tanning. OBJECTIVES: To investigate the transcriptional response to fluorescent solar-simulated radiation (FSSR) in sun-sensitive human skin in vivo. METHODS: Seven healthy male volunteers were exposed to 0, 3 and 6 standard erythemal doses (SED). Skin biopsies were taken at 6 h and 24 h after exposure. Gene and microRNA expression were quantified with next generation sequencing. A set of candidate genes was validated by quantitative polymerase chain reaction (qPCR); and wavelength dependence was examined in other volunteers through microarrays. RESULTS: The number of differentially expressed genes increased with FSSR dose and decreased between 6 and 24 h. Six hours after 6 SED, 4071 genes were differentially expressed, but only 16 genes were affected at 24 h after 3 SED. Genes for apoptosis and keratinization were prominent at 6 h, whereas inflammation and immunoregulation genes were predominant at 24 h. Validation by qPCR confirmed the altered expression of nine genes detected under all conditions; genes related to DNA repair and apoptosis; immunity and inflammation; pigmentation; and vitamin D synthesis. In general, candidate genes also responded to UVA1 (340-400 nm) and/or UVB (300 nm), but with variations in wavelength dependence and peak expression time. Only four microRNAs were differentially expressed by FSSR. CONCLUSIONS: The UV radiation doses of this acute study are readily achieved daily during holidays in the sun, suggesting that the skin transcriptional profile of 'typical' holiday makers is markedly deregulated. What's already known about this topic? The skin's transcriptional profile underpins its adverse (i.e. inflammation) and adaptive molecular, cellular and clinical responses (i.e. tanning, hyperkeratosis) to solar ultraviolet radiation. Few studies have assessed microRNA and gene expression in vivo in humans, and there is a lack of information on dose, time and waveband effects. What does this study add? Acute doses of fluorescent solar-simulated radiation (FSSR), of similar magnitude to those received daily in holiday situations, markedly altered the skin's transcriptional profiles. The number of differentially expressed genes was FSSR-dose-dependent, reached a peak at 6 h and returned to baseline at 24 h. The initial transcriptional response involved apoptosis and keratinization, followed by inflammation and immune modulation. In these conditions, microRNA expression was less affected than gene expression.
Assuntos
Neoplasias Cutâneas , Raios Ultravioleta , Relação Dose-Resposta à Radiação , Eritema/genética , Humanos , Masculino , Pele , Transcriptoma , Raios Ultravioleta/efeitos adversosAssuntos
Proteínas de Ciclo Celular/genética , Contratura/genética , Fibrose Pulmonar/genética , Esclerose/complicações , Anormalidades da Pele/complicações , Dermatopatias Genéticas/complicações , Tendões/patologia , Adolescente , Adulto , Atrofia/genética , Atrofia/patologia , Criança , Pré-Escolar , Eritema/genética , Eritema/patologia , Feminino , Seguimentos , Humanos , Lactente , Linfedema/genética , Linfedema/patologia , Masculino , Pessoa de Meia-Idade , Mutação , Estudos Retrospectivos , Esclerose/genética , Esclerose/patologia , Pele/patologia , Anormalidades da Pele/genética , Anormalidades da Pele/patologia , Dermatopatias Genéticas/genética , Dermatopatias Genéticas/patologia , Adulto JovemRESUMO
BACKGROUND: Our previous double-blinded, placebo-controlled cross-over study indicated that a nutritional supplement named lycopene-rich tomato nutrient complex (TNC) can protect from UVA1-induced (340-400 nm) and UVA- (320-400 nm)/UVB-induced (280-320 nm) upregulation of molecular markers associated with oxidative stress, inflammation, and ageing. OBJECTIVES: in the current double-blind, randomized, placebo-controlled multicenter study, we analyze whether a similar, synergistic carotenoid-rich TNC can protect from broadband UVB-induced threshold erythema formation assessed as increase in minimal erythemal dose (MED) reading, the intensity of erythema formation, and the upregulation of molecular markers associated with inflammation and immunosuppression, and whether this correlates with carotenoid blood levels. METHODS: One hundred and forty-nine healthy volunteers were randomized to two groups and subjected to a 5-week washout phase, followed by a 12-week treatment phase receiving either 15 mg lycopene, 5.8 mg phytoene and phytofluene, 0.8 mg ß-carotene, 5.6 mg tocopherols from tomato extract, and 4 mg carnosic acid from rosemary extract per day or placebo made from medium-chain triglycerides. At the end of each phase, MED determination, UVB irradiation, chromametry, biopsies, and blood samples were undertaken. RESULTS: The active supplement was well tolerated. Interestingly, no significant difference was seen in the MED between the active-supplement and placebo groups, as determined by visual grading by expert assessors. Of note, the carotenoid-containing supplement significantly protected against UVB-induced erythema formation measured as Δa* after the intervention minus Δa* after the washout phase as compared to the placebo. Moreover, intake of the active supplement significantly protected against UVB-induced upregulation of IL6 and TNFα as compared with the intake of placebo. Lastly, carotenoid plasma levels were significantly increased. CONCLUSION: This well-tolerated carotenoid-containing supplement significantly protected against UVB-induced erythema formation and upregulation of proinflammatory cytokines in healthy volunteers.
Assuntos
Antioxidantes/farmacologia , Carotenoides/farmacologia , Suplementos Nutricionais , Eritema/prevenção & controle , Compostos Fitoquímicos/farmacologia , Protetores contra Radiação/farmacologia , Solanum lycopersicum/química , Raios Ultravioleta/efeitos adversos , Adulto , Citocinas/genética , Método Duplo-Cego , Eritema/genética , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos da radiação , Humanos , Masculino , Pessoa de Meia-Idade , Pele/efeitos dos fármacos , Pele/metabolismo , Pele/efeitos da radiação , Adulto JovemAssuntos
Síndrome de Bloom/diagnóstico , Síndrome de Bloom/genética , Eritema/diagnóstico , Eritema/genética , Indígenas Norte-Americanos/genética , Síndrome de Bloom/complicações , Criança , Diagnóstico Diferencial , Eritema/complicações , Face/patologia , Humanos , Indígenas Norte-Americanos/etnologia , Masculino , México/etnologiaRESUMO
Skin color diversity is the most variable and noticeable phenotypic trait in humans resulting from constitutive pigmentation variability. This paper will review the characterization of skin pigmentation diversity with a focus on the most recent data on the genetic basis of skin pigmentation, and the various methodologies for skin color assessment. Then, melanocyte activity and amount, type and distribution of melanins, which are the main drivers for skin pigmentation, are described. Paracrine regulators of melanocyte microenvironment are also discussed. Skin response to sun exposure is also highly dependent on color diversity. Thus, sensitivity to solar wavelengths is examined in terms of acute effects such as sunburn/erythema or induced-pigmentation but also long-term consequences such as skin cancers, photoageing and pigmentary disorders. More pronounced sun-sensitivity in lighter or darker skin types depending on the detrimental effects and involved wavelengths is reviewed.
Assuntos
Dermatopatias/etiologia , Pigmentação da Pele , Raios Ultravioleta/efeitos adversos , Animais , Eritema/etiologia , Eritema/genética , Eritema/metabolismo , Predisposição Genética para Doença , Humanos , Melaninas/análise , Melaninas/genética , Melaninas/metabolismo , Fenótipo , Transtornos da Pigmentação/etiologia , Transtornos da Pigmentação/genética , Transtornos da Pigmentação/metabolismo , Polimorfismo de Nucleotídeo Único , Dermatopatias/genética , Dermatopatias/metabolismo , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/metabolismo , Pigmentação da Pele/efeitos da radiação , Queimadura Solar/etiologia , Queimadura Solar/genética , Queimadura Solar/metabolismoRESUMO
Bloom syndrome is an autosomal recessive condition characterized by severe pre- and postnatal growth deficiency, immunodeficiency, an increased risk for malignancies, craniofacial dysmorphisms, and "typical" erythematous sun-sensitive skin lesions of the face. This facial rash has a butterfly-shaped distribution around the nose and is usually observed for the first time during the early years of life. Though reported as being a main feature of Bloom syndrome, there seems to be phenotypic variability regarding this facial skin rash among patients. It has been previously reported that in some individuals with Bloom syndrome these sun-sensitive lesions are less prominent or even absent. In this report we describe a 36 year old woman with short stature, microcephaly, several dysmorphisms, congenital hypothyroidism and premature ovarian failure. She was diagnosed with nasopharyngeal carcinoma at 36 years of age, only a few months after her consultation at the department of Clinical Genetics. Whole Exome Sequencing demonstrated that she had Bloom syndrome caused by a compound heterozygous mutation in BLM (c.2207_2212delinsTAGATTC; p.(Tyr736Leufs*5) and c.3681del; p.(Lys1227Asnfs*52)). She did not have facial sun-sensitive erythematous rash during childhood nor adulthood. We conclude that Bloom syndrome does not always present with erythematous sun-sensitive skin lesions of the face. We would like to underline that phenotypic variation regarding this "hallmark" feature of Bloom syndrome exists. Being aware of this might prevent a delay in diagnosing this rare short-stature syndrome and, subsequently, its potential clinical implications.
Assuntos
Síndrome de Bloom/patologia , Eritema/patologia , Fenótipo , Adulto , Síndrome de Bloom/genética , Diagnóstico Diferencial , Eritema/etiologia , Eritema/genética , Feminino , Humanos , RecQ Helicases/genética , Luz Solar/efeitos adversosAssuntos
Erros Inatos do Metabolismo dos Carboidratos/diagnóstico , Contratura/diagnóstico , Eritema/diagnóstico , L-Lactato Desidrogenase/deficiência , Mialgia/diagnóstico , Dermatopatias Genéticas/diagnóstico , Adulto , Erros Inatos do Metabolismo dos Carboidratos/genética , Contratura/enzimologia , Contratura/etiologia , Contratura/genética , Diagnóstico Diferencial , Eritema/enzimologia , Eritema/etiologia , Eritema/genética , Humanos , L-Lactato Desidrogenase/genética , Extremidade Inferior/patologia , Masculino , Atividade Motora , Mialgia/enzimologia , Mialgia/etiologia , Mialgia/genética , Dermatopatias Genéticas/enzimologia , Dermatopatias Genéticas/etiologia , Dermatopatias Genéticas/genéticaAssuntos
Epidermólise Bolhosa Simples/genética , Eritema/genética , Queratina-5/genética , Vesícula/etiologia , Vesícula/genética , Criança , Epidermólise Bolhosa Simples/complicações , Eritema/etiologia , Humanos , Hiperpigmentação/etiologia , Hiperpigmentação/genética , Masculino , Deleção de SequênciaRESUMO
Keratolytic winter erythema (KWE) is a rare autosomal-dominant skin disorder characterized by recurrent episodes of palmoplantar erythema and epidermal peeling. KWE was previously mapped to 8p23.1-p22 (KWE critical region) in South African families. Using targeted resequencing of the KWE critical region in five South African families and SNP array and whole-genome sequencing in two Norwegian families, we identified two overlapping tandem duplications of 7.67 kb (South Africans) and 15.93 kb (Norwegians). The duplications segregated with the disease and were located upstream of CTSB, a gene encoding cathepsin B, a cysteine protease involved in keratinocyte homeostasis. Included in the 2.62 kb overlapping region of these duplications is an enhancer element that is active in epidermal keratinocytes. The activity of this enhancer correlated with CTSB expression in normal differentiating keratinocytes and other cell lines, but not with FDFT1 or NEIL2 expression. Gene expression (qPCR) analysis and immunohistochemistry of the palmar epidermis demonstrated significantly increased expression of CTSB, as well as stronger staining of cathepsin B in the stratum granulosum of affected individuals than in that of control individuals. Analysis of higher-order chromatin structure data and RNA polymerase II ChIA-PET data from MCF-7 cells did not suggest remote effects of the enhancer. In conclusion, KWE in South African and Norwegian families is caused by tandem duplications in a non-coding genomic region containing an active enhancer element for CTSB, resulting in upregulation of this gene in affected individuals.
Assuntos
Catepsina B/metabolismo , Elementos Facilitadores Genéticos , Eritema/genética , Duplicação Gênica , Regulação da Expressão Gênica , Ceratose/genética , Dermatopatias Genéticas/genética , Estudos de Casos e Controles , Catepsina B/genética , Mapeamento Cromossômico , Cromossomos Humanos Par 8/genética , Variações do Número de Cópias de DNA , DNA Glicosilases/genética , DNA Glicosilases/metabolismo , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/genética , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/metabolismo , Epiderme/metabolismo , Epigenômica , Eritema/epidemiologia , Feminino , Marcadores Genéticos , Humanos , Queratinócitos/metabolismo , Ceratose/epidemiologia , Células MCF-7 , Masculino , Noruega/epidemiologia , Linhagem , Dermatopatias Genéticas/epidemiologia , África do Sul/epidemiologiaRESUMO
Epidermal filaggrin level is affected by ultraviolet B irradiation in animal and experimental models. This study examined the effect of ultraviolet B irradiation on epidermal filaggrin and natural moisturizing factors in vivo in healthy adults (n = 22). Participants were irradiated with 2 minimal erythema doses of ultraviolet B on the skin. Biopsies and tape strips were collected from skin irradiated 24 and 72 h earlier and from non-irradiated skin (control). Real-time quantitative PCR on skin biopsies showed significantly reduced profilaggrin mRNA expression 24 h after irradiation (mean relative mRNA expression ± standard deviation: control, 3.86 ± 2.06 vs. 24 h, 1.52 ± 0.640; p = 0.02; n = 8). Immunohistochemistry showed aberrant spatial distribution of filaggrin protein 72 h after irradiation (n = 3). High-pressure liquid chromatography of tape extracts showed no change in mean total natural moisturizing factor levels after irradiation, but mean trans-urocanic acid was significantly reduced, as expected (n = 8). In conclusion, erythemal doses of ultraviolet B exert acute effects on profilaggrin mRNA and filaggrin protein in human skin in vivo.
Assuntos
Eritema/etiologia , Proteínas de Filamentos Intermediários/metabolismo , Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Adulto , Estudos de Casos e Controles , Regulação para Baixo , Eritema/genética , Eritema/metabolismo , Eritema/patologia , Feminino , Proteínas Filagrinas , Voluntários Saudáveis , Humanos , Proteínas de Filamentos Intermediários/genética , Masculino , Pessoa de Meia-Idade , Proteólise , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Pele/metabolismo , Pele/patologia , Fatores de Tempo , Ácido Urocânico/metabolismo , Adulto JovemRESUMO
BACKGROUND: The role of immunological factors in atopic dermatitis (AD) pathogenesis is well established. T-helper (TH) cells are central in AD pathogenesis. A relatively new subset of T cells, Th9 cells, was shown to be involved in the development of allergic asthma and allergic rhinitis, while its role in AD is still to be investigated. This study aimed to measure gene expression levels of interleukin-9 (IL-9) and PU.1, and to examine relationships with disease severity, serum IgE, and eruption types in AD patients. METHODS: The study enrolled 30 AD patients, 30 psoriasis patients, and 30 healthy subjects. The severity of AD was assessed using the SCORAD index. IL-9 and PU.1 expressions were measured by using real-time quantitative polymerase chain reaction (RQ-PCR). Serum IgE was measured by IgE (human) enzyme-linked immunosorbent assay (ELISA) Kit. RESULTS: IL-9 and PU.1 gene expressions were significantly higher in AD patients than in controls (P1 = 0.007, P2 < 0.001, respectively). In the atopic dermatitis patients, expression of IL-9 and PU.1 were significantly positively correlated with SCORAD index (P1 = 0.004, P2 = 0.002) and clinically with erythema and edema scores. IL-9 and PU.1 expressions were positively significantly correlated (P = 0.005) and positively correlated with serum IgE in the AD group (P1 = 0.017, P2 = 0.023). No significant difference was noted between AD patients with or without histories of other atopies regarding expression levels of IL-9 and PU.1 (P1 = 0.677, P2 = 0.135). CONCLUSIONS: PU.1 and IL-9 may play a role in AD pathogenesis and relate to disease severity and clinical eruption types.
Assuntos
Dermatite Atópica/sangue , Dermatite Atópica/genética , Interleucina-9/genética , Proteínas Proto-Oncogênicas/genética , Transativadores/genética , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Pré-Escolar , Edema/genética , Eritema/genética , Feminino , Expressão Gênica , Humanos , Imunoglobulina E/sangue , Masculino , Prurido/genética , Psoríase/genética , Índice de Gravidade de Doença , Exacerbação dos Sintomas , Adulto JovemAssuntos
Proteínas Adaptadoras de Sinalização CARD/genética , Proteínas de Ligação ao Cálcio/genética , Eritema/genética , Doenças Hereditárias Autoinflamatórias/genética , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Artralgia/tratamento farmacológico , Artralgia/genética , Citocinas/metabolismo , Enterocolite/tratamento farmacológico , Enterocolite/genética , Exantema/tratamento farmacológico , Exantema/genética , Feminino , Doenças Hereditárias Autoinflamatórias/tratamento farmacológico , Humanos , Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico , Masculino , Pessoa de Meia-Idade , Linhagem , Fenótipo , Urticária/tratamento farmacológico , Urticária/genéticaAssuntos
DNA/genética , Epidermólise Bolhosa Simples/genética , Eritema/genética , Mutação da Fase de Leitura , Queratina-5/genética , Biópsia , Pré-Escolar , Análise Mutacional de DNA , Epidermólise Bolhosa Simples/complicações , Epidermólise Bolhosa Simples/diagnóstico , Eritema/complicações , Eritema/diagnóstico , Feminino , Humanos , Queratina-5/metabolismo , Masculino , Linhagem , Fenótipo , Pele/patologiaAssuntos
Eritema/etiologia , Predisposição Genética para Doença , Genótipo , Proteínas de Filamentos Intermediários/genética , Raios Ultravioleta/efeitos adversos , Adulto , Estudos de Casos e Controles , Eritema/genética , Proteínas Filagrinas , Marcadores Genéticos , Humanos , Proteínas de Filamentos Intermediários/deficiência , MutaçãoAssuntos
Conexinas/genética , Eritema/genética , Ceratose/genética , Proteínas de Membrana/genética , Mutação , Feminino , Humanos , MasculinoRESUMO
OBJECTIVES: The purpose of this study was to identify associations between ALDH2 and ADH1B genotypes and ethanol-induced cutaneous erythema and assess the accuracy of an ethanol patch test in young Japanese women. METHODS: The subjects were 942 female Japanese university students. They were given an ethanol patch test and examined for ethanol-induced cutaneous erythema both immediately after removing the patch and 10 minutes after removing the patch. A saliva sample was used to determine the ALDH2 and ADH1B genotype of each subject by realtime PCR. RESULTS: The sensitivity and specificity of erythema immediately after removing the patch as the marker for the presence of inactive ALDH2 were 69.6% and 87.7%, respectively, and the sensitivity and specificity of erythema 10 minutes after removing the patch were 85.2% and 85.1%, respectively. The sensitivity of erythema after 10 minutes was markedly lower in the ADH1B*1/*1 carriers than in the ADH1B*2 carriers (8.3% vs. 89.7%, p<0.0001), and the specificity was significantly higher in the ADH1B*1/*1 carriers than in the ADH1B*2 carriers (96.9% vs. 84.3%, p<0.05). CONCLUSIONS: Overall, both sensitivity and specificity were satisfactorily high, but having the ADH1B*1/*1 genotype prevented a positive reaction for inactive ALDH2 and caused false-negative results. The data also suggested that having the ADH1B*2/*2 genotype caused a positive reaction in subjects with the ALDH2*1/*1 genotype. Despite these exceptions, the ethanol patch test has enough accuracy and can be used easily to subjects who don't drink alcohol. This is a valuable tool for improving the health literacy of younger generation subjects.